Advertisement

Jyoti D. Patel on the Progress of Immunotherapy in NSCLC

Published on: 

Jyoti D. Patel, ASCO expert, associate professor, Northwestern University Feinberg School of Medicine, discusses the progress of immunotherapy as treatment for patients with non-small cell lung cancer.

Jyoti D. Patel, ASCO expert, associate professor, Northwestern University Feinberg School of Medicine, discusses the progress of immunotherapy as treatment for patients with non-small cell lung cancer (NSCLC). Patel is reporting on data presented at the 2015 annual meeting of the American Society of Clinical Oncology, a gathering of nearly 30,000 oncology professionals in Chicago.

Related Content:

CURE TVImmunotherapyLung Cancer
Tumor Treating Fields With Standard of Care May Significantly Improve Survival in Metastatic NSCLC
Pre- and Post-Surgical Keytruda Boosts Outcomes in Early NSCLC
Final Open Mic Showcase Features Cancer Comedy, Other Acts
Advertisement
Advertisement